103 related articles for article (PubMed ID: 17390087)
1. Sodium diethyldithiocarbamate, an AIDS progression inhibitor and a copper-binding compound, has proteasome-inhibitory and apoptosis-inducing activities in cancer cells.
Pang H; Chen D; Cui QC; Dou QP
Int J Mol Med; 2007 May; 19(5):809-16. PubMed ID: 17390087
[TBL] [Abstract][Full Text] [Related]
2. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP
Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104
[TBL] [Abstract][Full Text] [Related]
3. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity.
Chen D; Cui QC; Yang H; Dou QP
Cancer Res; 2006 Nov; 66(21):10425-33. PubMed ID: 17079463
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of copper-dependent proteasome-inhibitory and apoptosis-inducing activities of novel pyrrolidine dithiocarbamate analogues.
Yu Z; Wang F; Milacic V; Li X; Cui QC; Zhang B; Yan B; Dou QP
Int J Mol Med; 2007 Dec; 20(6):919-25. PubMed ID: 17982703
[TBL] [Abstract][Full Text] [Related]
5. A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts.
Han J; Liu L; Yue X; Chang J; Shi W; Hua Y
Toxicol Appl Pharmacol; 2013 Dec; 273(3):477-83. PubMed ID: 24060341
[TBL] [Abstract][Full Text] [Related]
6. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.
Milacic V; Chen D; Ronconi L; Landis-Piwowar KR; Fregona D; Dou QP
Cancer Res; 2006 Nov; 66(21):10478-86. PubMed ID: 17079469
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibition blocks caspase-8 degradation and sensitizes prostate cancer cells to death receptor-mediated apoptosis.
Thorpe JA; Christian PA; Schwarze SR
Prostate; 2008 Feb; 68(2):200-9. PubMed ID: 18076022
[TBL] [Abstract][Full Text] [Related]
9. Novel Schiff base copper complexes of quinoline-2 carboxaldehyde as proteasome inhibitors in human prostate cancer cells.
Adsule S; Barve V; Chen D; Ahmed F; Dou QP; Padhye S; Sarkar FH
J Med Chem; 2006 Nov; 49(24):7242-6. PubMed ID: 17125278
[TBL] [Abstract][Full Text] [Related]
10. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells.
Kim J; Park H; Im JY; Choi WS; Kim HS
Anticancer Res; 2007; 27(5A):3285-92. PubMed ID: 17970072
[TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade.
Yerlikaya A; Erin N
Int J Mol Med; 2008 Dec; 22(6):817-23. PubMed ID: 19020781
[TBL] [Abstract][Full Text] [Related]
12. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
13. Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.
Zoubeidi A; Zardan A; Beraldi E; Fazli L; Sowery R; Rennie P; Nelson C; Gleave M
Cancer Res; 2007 Nov; 67(21):10455-65. PubMed ID: 17974989
[TBL] [Abstract][Full Text] [Related]
14. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic properties of sodium diethyldithiocarbamate: its role as an inhibitor in the progression of AIDS.
Sunderman FW
Ann Clin Lab Sci; 1991; 21(1):70-81. PubMed ID: 1849385
[TBL] [Abstract][Full Text] [Related]
16. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY
Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429
[TBL] [Abstract][Full Text] [Related]
17. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells.
Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
J Cell Biochem; 2008 Jan; 103(1):270-83. PubMed ID: 17516511
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects.
Chen D; Frezza M; Shakya R; Cui QC; Milacic V; Verani CN; Dou QP
Cancer Res; 2007 Oct; 67(19):9258-65. PubMed ID: 17909033
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells.
Im JY; Park H; Kang KW; Choi WS; Kim HS
Chem Biol Interact; 2008 Apr; 172(3):235-44. PubMed ID: 18313654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]